N-(PHOSPHONOACETYL)AMINO PHOSPHONATES - PHOSPHONATE ANALOGS OF N-(PHOSPHONOACETYL)-L-ASPARTIC ACID (PALA)

被引：27
|
作者：
KAFARSKI, P
LEJCZAK, B
MASTALERZ, P
DUS, D
RADZIKOWSKI, C
机构：
[1] WROCLAW TECH UNIV,INST ORGAN & PHYS CHEM,PL-50370 WROCLAW,POLAND
[2] POLISH ACAD SCI,INST IMMUNOL & EXPTL THERAPY,DEPT TUMOR IMMUNOL,PL-53114 WROCLAW,POLAND
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1985年 / 28卷 / 11期
关键词：
D O I：
10.1021/jm00149a002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1555 / 1558
页数：4
相关论文
共 50 条
  • [41] A PHASE I-II STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ADDED TO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER
    JODRELL, DI
    OSTER, W
    KERR, DJ
    CANNEY, PA
    YOSEF, H
    STEWARD, WP
    KAYE, SB
    CASSIDY, J
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 950 - 954
  • [42] N-(Fluoren-9-ylmethoxycarbonyl)-L-aspartic acid 4-tert-butyl ester
    Yamada, Kazuhiko
    Hashizume, Daisuke
    Shimizu, Tadashi
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O2606 - U2373
  • [43] Synthesis and biological evaluation of N-(carbobenzyloxy)-L-phenylalanine and N-(carbobenzyloxy)-L-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors
    Han, Xiaoyan
    Zhong, Yifan
    Zhou, Guan
    Qi, Hui
    Li, Shengbin
    Ding, Qiang
    Liu, Zhenming
    Song, Yali
    Qiao, Xiaoqiang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (12) : 3116 - 3126
  • [44] Synthesis and biological evaluation of S-acyl-3-thiopropyl prodrugs of N-phosphonoacetyl-L-aspartate (PALA)
    Gagnard, V
    Leydet, A
    Le Mellay, W
    Aubenque, M
    Morère, A
    Montero, JL
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (10) : 883 - 891
  • [45] ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID, A TRANSITION-STATE INHIBITOR OF ASPARTATE-TRANSCARBAMYLASE
    JOHNSON, RK
    INOUYE, T
    GOLDIN, A
    STARK, GR
    CANCER RESEARCH, 1976, 36 (08) : 2720 - 2725
  • [46] THE REACTION OF N-(PURIN-6-YL)-L-ASPARTIC ACID AND RELATED-COMPOUNDS WITH COPPER(II)
    BALLIO, A
    GAZZETTA CHIMICA ITALIANA, 1986, 116 (09): : 519 - 521
  • [47] COMBINATION CHEMOTHERAPY WITH ACIVICIN, N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) AND ARA-C AGAINST CD8F1 BREAST-TUMORS
    STOLFI, RL
    MARTIN, DS
    SAWYER, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 241 - 241
  • [48] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THYMIDINE (TDR), 5-FLUOROURACIL (5FU) AND N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) IN COMBINATION
    CHIUTEN, DF
    BENVENUTO, J
    HO, DH
    BODEY, GP
    FREIREICH, EJ
    VALDIVIESO, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 358 - 358
  • [49] BIOSYNTHESIS OF PURINES .27. N-(5-AMINO-1-RIBOSYL-4-IMIDAZOLYLCARBONYL)-L-ASPARTIC ACID 5'-PHOSPHATE KINOSYNTHETASE
    MILLER, RW
    BUCHANAN, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1962, 237 (02) : 485 - +
  • [50] SYNTHESIS OF N-(5-AMINO-1-BETA-D-RIBOFURANOSYL-4-IMIDAZOLYLCARBONYL)-L-ASPARTIC ACID 5''-O-PHOSPHATE
    SHAW, G
    WILSON, DV
    PROCEEDINGS OF THE CHEMICAL SOCIETY OF LONDON, 1962, (MAR): : 115 - &
12345